Auszug der Publikationen zum Download
- Can Oral Bisphosphonates Really Reduce the Risk of Breast Cancer in Healthy Women?
J Clin Oncol June, 2010 - Fighting overtreatment in adjuvant breast cancer therapy
Lancet Oncology 2010 - Closing in on the unknown enemy
Lancet Oncology 2010 - Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
N Engl J Med 2009;360:679-91. - Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
J Clin Oncol 28:509-518., 2009 - Cryopreservation of Monocytes Is Superior to Cryopreservation of Immature or Semi-mature Dendritic Cells for Dendritic Cell-based Immunotherapy
J Immunother Volume 32, Number 6, July-August 2009 - To Measure the Unmeasurable
World J Surg (2009) 33:52–53 - Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
Lancet Oncol 2008; 9: 840–49 - Moderne Tumortherapie des Pankreaskarzinoms
Journal für Gastroenterologische und Hepatologische Erkrankungen 2008; 6 (3), 17-24 - Low telomerase activity: Possible role in the progression of human medullary thyroid carcinoma
EUROPEAN JOURNAL OF CANCER 4 4 ( 2 0 0 8 ) 8 6 6 –8 7 5 - Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
Annals of Oncology 19: 420–432, 2008 - Cystic neoplasms of the pancreas: conservative or operative treatment?
Eur Surg (2008) 40/5: 220–226 - Lumpectomy plus Tamoxifen or Anastrozole with or without whole breast irradiation in women with favorable early breast cancer
Int. J. Radiation Oncology Biol. Phys., Vol. 68, No. 2, pp. 334–340, 2007 - Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials
The Lancet, Vol 369 May 19, 2007 - Extended Adjuvant Therapy With Anastrozole Among Postmenopausal Breast Cancer Patients: Results From the Randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a
JNCI Vol. 99, Issue 24 December 19, 2007 - Heat Shock Treatment of Tumor Lysate-Pulsed Dendritic Cells Enhances Their Capacity to Elicit Antitumor T Cell Responses against Medullary Thyroid Carcinoma
The Journal of Clinical Endocrinology & Metabolism 91(11):4571–4577, 2006
